How Do Smoking and Immunosuppression Affect VaIN Recurrence?

Smoking and a weakened immune system—whether from HIV, an organ transplant, or immune-suppressing medications—can make it harder for your body to manage the human papillomavirus (HPV) and may increase the risk of Vaginal Intraepithelial Neoplasia (VaIN) persisting or returning after treatment. While you can quit smoking to support your body’s immune response, you should never stop taking prescribed immune-suppressing medications without consulting your specialist. Instead, managing VaIN alongside these conditions requires individualized, long-term follow-up and close coordination between your gynecologist and your other specialists.

The Immune System, HPV, and VaIN

VaIN refers to abnormal, precancerous cells in the lining of the vagina. It is often discovered when a doctor investigates a white patch (leukoplakia) using a biopsy. Not every white patch is VaIN, and not all VaIN is caused by HPV. However, most high-grade VaIN is strongly linked to a persistent (long-lasting) infection with high-risk strains of HPV.

Your immune system is responsible for controlling this virus. When your immune system is suppressed, HPV is more likely to remain detectable, which is a major risk factor for VaIN returning after treatment ^[1][2]. Observational studies suggest that being immunocompromised may substantially increase the risk of VaIN treatments failing or the disease recurring ^[3], though your exact risk depends on your specific condition, the grade of your VaIN, and your treatments.

• HIV: HIV reduces the immune system’s ability to clear HPV, especially if your CD4 count (a marker of immune health) is low ^[4]. Taking antiretroviral therapy (ART) is essential for restoring immune function and may reduce the risk of early cell changes progressing ^[4]. However, ART is not a treatment for VaIN itself and does not guarantee the virus will clear ^[5]. People living with HIV also have a higher risk of developing VaIN in multiple spots at the same time (multifocal disease) ^[5][6].
• Organ Transplants and Autoimmune Medications: Medications taken after a solid organ transplant or for severe autoimmune diseases deliberately suppress the immune system. This increases the risk of developing vaginal and vulvar precancers compared to the general population ^[7][8]. These medications are life-saving. Any changes to your regimen must be carefully managed by your transplant specialist or rheumatologist.

Why Smoking Matters

Smoking is a known, modifiable risk factor linked to the development of VaIN ^[9][10]. Tobacco use can impair local immune cells in the lower genital tract. Because ongoing HPV infection strongly predicts whether VaIN will return ^[1][2], quitting smoking is a beneficial step for your overall health and may help lower the chance of the disease persisting.

While quitting does not guarantee the virus will disappear, it is something you can actively control. Ask your doctor for concrete support, such as state quitlines, behavioral counseling, nicotine replacement therapies, or prescription options.

Tailoring Your Care and Surveillance

If you have an immune-suppressing condition or smoke, your VaIN management plan must be personalized.

• Careful, long-term follow-up (surveillance): Post-treatment surveillance for VaIN is different from a routine cervical Pap smear. Guidelines often suggest a follow-up assessment starting 6 months after treatment, using an HPV test and vaginal cytology (swabbing for abnormal cells) ^[11]. For immunocompromised patients, experts often recommend more intensive, long-term screening because VaIN can recur many years later ^[12][5].
• What abnormal results mean: A swab test alone cannot confirm the exact grade of disease. If a follow-up test is abnormal, your doctor will likely recommend a colposcopy (a magnified exam of the vagina) and a biopsy to check for returning VaIN.
• The HPV vaccine: The HPV vaccine prevents new HPV infections; it does not cure existing HPV or treat VaIN. It is recommended as a 3-dose series for immunocompromised individuals up to age 26, and through shared decision-making up to age 45 ^[13]. When feasible, completing the series before an organ transplant may provide a stronger immune response ^[13], but vaccination should not delay urgent medical treatments.
• When to call your doctor: Do not wait for your scheduled screening if you notice new symptoms like unusual watery or bloody discharge, vaginal bleeding (especially after sex), pelvic pain, or a new visible patch or lump. These symptoms do not prove VaIN has returned, but they require prompt evaluation.